Rivastigmine - EXELON 4,6 mg/24 h, dispositif transdermique

Business Listing - December 25, 2019

Rivastigmine EXELON 4,6 mg/24 h, dispositif transdermique - N06DA03 NOVARTIS EUROPHARM (ROYAUME-UNI) - 67885398

This is a premium business listing. Stand out from the competition!

List your company and reach more customers today.